Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Pathologie-Biologie
|
May 1, 1983
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice]
J Grosset, C Truffot-Pernot, H Lecoeur, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
HIV, cytokines and programmed cell death. A subtle interplay
M L Gougeon, E Ledru, H Naora, et al.
Journal of Immunological Methods
|
June 1, 2001
A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity
H Lecoeur, M Février, S Garcia, et al.
Chest
|
July 14, 2001
Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France
B Fantin, J P Aubert, P Unger, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1990
Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil
L Couraud, J M Andrews, H Lecoeur, et al.
Cell Death and Differentiation
|
October 1, 1995
The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated thymocytes
J F Torres-Roca, H Lecoeur, C Amatore, et al.
Revue Des Maladies Respiratoires
|
January 1, 1985
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]
J Grosset, C Truffot-Pernot, S Poggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 8, 1998
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis
E Ledru, H Lecoeur, S Garcia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 18, 1998
Pro-apoptotic effect of the hepatitis B virus X gene
T Pollicino, O Terradillos, H Lecoeur, et al.
Immunology Letters
|
June 1, 1997
Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection
S Garcia, M Fevrier, G Dadaglio, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Pathologie-Biologie
|
May 1, 1983
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice]
J Grosset, C Truffot-Pernot, H Lecoeur, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
HIV, cytokines and programmed cell death. A subtle interplay
M L Gougeon, E Ledru, H Naora, et al.
Journal of Immunological Methods
|
June 1, 2001
A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity
H Lecoeur, M Février, S Garcia, et al.
Chest
|
July 14, 2001
Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France
B Fantin, J P Aubert, P Unger, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1990
Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil
L Couraud, J M Andrews, H Lecoeur, et al.
Cell Death and Differentiation
|
October 1, 1995
The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated thymocytes
J F Torres-Roca, H Lecoeur, C Amatore, et al.
Revue Des Maladies Respiratoires
|
January 1, 1985
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]
J Grosset, C Truffot-Pernot, S Poggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 8, 1998
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis
E Ledru, H Lecoeur, S Garcia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 18, 1998
Pro-apoptotic effect of the hepatitis B virus X gene
T Pollicino, O Terradillos, H Lecoeur, et al.
Immunology Letters
|
June 1, 1997
Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection
S Garcia, M Fevrier, G Dadaglio, et al.
Page
of 5